December 31false0001932591Q2New York2024-01-312027-12-312023-12-312029-11-302023-09-302026-10-312024-03-312028-07-302025-02-282030-03-312023-10-312028-01-312025-06-302030-06-302023-11-302030-11-302023-05-312029-05-312023-11-302029-11-302024-04-302029-10-312024-07-312027-07-312025-01-312029-02-282024-09-302027-07-312024-03-312029-01-312023-10-312029-10-312023-12-312027-02-272024-08-312027-12-312023-12-312028-11-302024-04-302028-07-312024-12-312028-04-302025-03-312028-03-312024-06-302029-06-302025-03-312030-03-312024-05-312026-07-312024-01-312029-02-282025-03-312028-03-312023-08-312030-08-312023-03-312029-03-312023-09-302027-09-302025-06-302028-12-312023-11-302030-11-302024-01-312027-10-312025-06-302030-06-302023-10-312030-04-30http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember2024-01-312027-12-312023-12-312029-11-302023-09-302026-10-312024-03-312028-07-312023-10-312028-01-312023-11-302030-11-302023-5-312029-05-312023-11-302029-11-302024-04-302029-10-312024-07-312027-07-312024-09-302027-07-312024-03-312029-01-312023-10-312029-10-312023-12-312027-02-282024-08-312027-12-312023-12-312028-11-302024-04-302026-07-312024-1-312027-11-302024-12-312028-04-302023-07-312028-11-302024-06-302029-06-302023-12-312026-01-312024-05-312026-07-312024-01-312029-02-282023-08-312030-08-312023-03-312029-03-312023-09-302025-09-302023-11-302030-11-302024-01-312027-10-312023-10-312028-04-30http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2024#UnrealizedGainLossOnInvestmentshttp://fasb.org/us-gaap/2024#UnrealizedGainLossOnInvestmentshttp://fasb.org/us-gaap/2024#UnrealizedGainLossOnInvestmentshttp://www.slrcapitalpartners.com/20250630#CoCEOMember0001932591Bank Debt/Senior Secured Loans — 259.9% | SPR Therapeutics, Inc. | Health Care Technology | S+515 | 4.00% | 9.47% | 1//2024 | 2/20292025-01-012025-06-3000019325912025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | FE Advance, LLC | Diversified Financial Services | S+650 | 1.00% | 10.86% | 7/2024 | 7/20272024-01-012024-12-3100019325912025-04-012025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMember2025-04-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Ardelyx, Inc. | Pharmaceuticals | S+400 | 4.70% | 8.70% | 3/2024 | 7/20282025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:HealthCareProvidersAndServicesMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | UVP Management, LLC | Health Care Providers & Services | S+625 | 1.00% | 10.73% | 9/2023 | 9/20252024-01-012024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:UnitedDigestiveMsoParentLlcMember2024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:WciBxcPurchaserLlcMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | MRI Software, LLC | Software | S+475 | 1.00% | 9.05% | 12/2023 | 2/20272025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Medrina, LLC | Health Care Providers & Services | S+600 | 1.00% | 10.13% | 10/2023 | 10/20292025-01-012025-06-300001932591us-gaap:InvestmentUnaffiliatedIssuerMember2025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberus-gaap:RetailMember2025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:WALCOFundingLLCMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | MRI Software, LLC | Software | S+475 | 1.00% | 9.05% | 12/2023 | 2/20272025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:ProfessionalServicesMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | WCI-BXC Purchaser, LLC | Distributors | S+625 | 0.75% | 10.51% | 11/2023 | 11/20302025-06-300001932591ck0001932591:CrewlineBuyerIncMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | The Townsend Company, LLC | Commercial Services & Supplies | S+500 | 1.00% | 9.30% | 8/2023 | 8/20302025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | United Digestive MSO Parent, LLC | Health Care Providers & Services | S+575 | 1.00% | 10.04% | 3/2023 | 3/20292025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | WALCO Funding, LLC | Financial Services | S+785 | 1.00%| 12.18%| 6/2025| 12/20282025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Stella & Chewy's LLC | Consumer Staples Distribution & Retail | S+525 | 2.00% | 9.58% | 3/2025 | 3/20282025-01-012025-06-300001932591ck0001932591:ArcutisBiotherapeticsIncMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591ck0001932591:CerapedicsInc.Memberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | The Townsend Company, LLC | Commercial Services & Supplies | S+500 | 1.00% | 9.30% | 8/2023 | 8/20302025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | ONS MSO, LLC | Health Care Providers & Services | S+575 | 1.00% | 10.03% | 4/2024 | 7/20282025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:HealthCareTechnologyMember2024-12-310001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMemberck0001932591:BankDebtAndSeniorSecuredLoansMembersrt:MaximumMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMember2023-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | WALCO Funding, LLC | Financial Services | S+785 | 1.00%| 12.18%| 6/2025| 12/20282025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:ExactcareParentIncMember2025-06-300001932591srt:MinimumMember2025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | AAH Topco., LLC | Diversified Consumer Services | S+525 | 0.75% | 9.67% | 1/2024 | 12/20272025-06-300001932591us-gaap:FairValueInputsLevel3Member2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+525 | 1.00% | 9.58% | 5/2024 | 7/20262024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:MedrinaLlcMember2024-12-310001932591ck0001932591:StellaChewysLLCMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591ck0001932591:NonControlledNonAffiliatedInvestmentsMember2025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | FE Advance, LLC | Diversified Financial Services | S+650 | 1.00% | 10.86% | 7/2024 | 7/20272024-12-310001932591ck0001932591:PharmaceuticalsMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Pasadena Private Lending Inc. | Diversified Financial Service | S+750 | 1.00% | 11.88% | 12/2024 | 4/20282024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | OIS Management Services, LLC | Health Care Providers & Services | S+475 | 0.75% | 9.08% | 12/2023 | 11/20282024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Pasadena Private Lending Inc | Financial Services | S+750 | 1.00% | 11.82% | 12/2024 | 4/20282025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Human Interest, Inc. | Internet Software & Services | S+735 | 1.00% | 11.90% | 9/2024 | 7/20272024-12-310001932591ck0001932591:AahTopcoLlcMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:HealthCareEquipmentAndSuppliesMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | The Townsend Company, LLC | Commercial Services & Supplies | S+500 | 1.00% | 9.36% | 8/2023 | 8/20302024-12-310001932591ck0001932591:SpvFacilityMember2023-12-122023-12-120001932591ck0001932591:BankDebtAndSeniorSecuredLoansMember2024-01-012024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:FoundationConsumerBrandsLlcMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | WCI-BXC Purchaser, LLC | Distributors | S+625 | 0.75% | 10.51% | 11/2023 | 11/20302025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | FE Advance, LLC & Sonic ACA Advance LLC | Financial Services | S+650 | 1.00% | 10.83% | 7/2024 | 7/20272025-01-012025-06-300001932591us-gaap:FairValueInputsLevel3Memberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Ardelyx, Inc. | Pharmaceuticals | S+400 | 4.70% | 8.70% | 3/2024 | 7/20282025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | AAH Topco., LLC | Diversified Consumer Services | S+525 | 0.75% | 9.71% | 01/2024 | 12/20272024-01-012024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:MedrinaLlcMember2025-06-300001932591ck0001932591:DiversifiedFinancialServicesMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591ck0001932591:CogentBiosciencesIncMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591ck0001932591:SubscriptionFacilityMember2024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Cerapedics, Inc. | Biotechnology | S+620 | 2.75% | 10.72% | 10/2023 | 1/20282024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Exactcare Parent, Inc. | Health Care Providers & Services | S+550 | 1.00% | 9.76% | 11/2023 | 11/20292025-06-300001932591us-gaap:FairValueInputsLevel3Memberck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-3000019325912024-04-012024-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:MriSoftwareLlcMember2024-12-310001932591ck0001932591:PharmaceuticalsMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Stella & Chewy's LLC | Consumer Staples Distribution & Retail | S+525 | 2.00% | 9.58% | 3/2025 | 3/20282025-06-300001932591us-gaap:WarrantMember2023-12-310001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMembersrt:WeightedAverageMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:WALCOFundingLLCMember2024-12-310001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMembersrt:MinimumMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | The Townsend Company, LLC | Commercial Services & Supplies | S+500 | 1.00% | 9.36% | 8/2023 | 8/20302024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Cogent Biosciences, Inc.| Biotechnology | S+475 | 4.15%| 9.06%| 6/2025| 6/20302025-06-3000019325912025-08-010001932591Bank Debt/Senior Secured Loans — 259.9% | UVP Management, LLC | Health Care Providers & Services | S+550 | 1.00% | 9.95% | 9/2023 | 9/20272025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | AAH Topco., LLC | Diversified Consumer Services | S+525 | 0.75% | 9.71% | 01/2024 | 12/20272024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Quantcast Corporation | Commercial Services & Supplies | S+525 | 2.00% | 11.75% | 6/2024 | 6/20292024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:HealthCareProvidersAndServicesMember2024-12-310001932591us-gaap:WarrantMember2024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Medrina, LLC | Health Care Providers & Services | S+600 | 1.00% | 10.44% | 10/2023 | 10/20292024-12-310001932591ck0001932591:NonControlledNonAffiliatedInvestmentsMember2024-04-012024-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | OIS Management Services, LLC | Health Care Providers & Services | S+475 | 0.75% | 9.01% | 12/2023 | 11/20282025-06-300001932591ck0001932591:SpreadTwoMember2025-06-300001932591ck0001932591:NonControlledNonAffiliatedInvestmentsMember2024-01-012024-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | UVP Management, LLC | Health Care Providers & Services | S+550 | 1.00% | 9.95% | 9/2023 | 9/20272025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Outset Medical, Inc. | Health Care Equipment & Supplies | S+515 | 2.75% | 9.67% | 1/2024 | 11/20272024-12-310001932591us-gaap:FairValueInputsLevel1Member2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Exactcare Parent, Inc. | Health Care Providers & Services | S+550 | 1.00% | 10.03% | 11/2023 | 11/20292024-12-310001932591ck0001932591:SpreadOneMember2024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:PasadenaPrivateLendingIncMember2024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:SprTherapeuticsIncMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+525 | 1.00% | 9.58% | 5/2024 | 7/20262024-01-012024-12-3100019325912024-06-300001932591us-gaap:WarrantMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Human Interest, Inc. | Internet Software & Services | S+735 | 1.00% | 11.90% | 9/2024 | 7/20272024-01-012024-12-310001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMembersrt:WeightedAverageMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:ProfessionalServicesMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | SPR Therapeutics, Inc. | Health Care Technology | S+515 | 4.00% | 9.47% | 1//2024 | 2/20292025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Legacy Service Partners, LLC | Diversified Consumer Services | S+525 | 1.00% | 9.73% | 3/2024 | 1/20292024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Peter C. Foy & Associates Insurance Services, LLC | Insurance | S+650 | 0.75% | 10.86% | 7/2023 | 11/20282024-01-012024-12-310001932591ck0001932591:SubscriptionFacilityMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | FE Advance, LLC & Sonic ACA Advance LLC | Financial Services | S+650 | 1.00% | 10.83% | 7/2024 | 7/20272025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:SoftwareMember2025-06-300001932591srt:MaximumMember2025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Cogent Biosciences, Inc.| Biotechnology | S+475 | 4.15%| 9.06%| 6/2025| 6/20302025-01-012025-06-300001932591ck0001932591:SubscriptionFacilityMember2025-01-012025-06-300001932591ck0001932591:SpvFacilityMember2023-12-120001932591Bank Debt/Senior Secured Loans — 259.9% | Western Veterinary Partners LLC | Diversified Consumer Services | S+525 | 1.00% | 9.31% | 1/2024 | 10/20272025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Crewline Buyer, Inc. | IT Services | S+675 | 1.00% | 11.08% | 11/2023 | 11/20302025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+550 | 1.00% | 9.80% | 5/2024 | 7/20262025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:SouthernOrthodonticsPartnersManagementLlcMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Alkeme Intermediary Holdings, LLC | Insurance | S+575 | 1.00% | 10.08% | 9/2023 | 10/20262024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:PinnacleFertilityIncMember2025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:ItServicesMember2025-06-300001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMembersrt:MaximumMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | World Insurance Associates, LLC | Insurance | S+575 | 1.00% | 10.08% | 10/2023 | 4/20282024-12-310001932591us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberck0001932591:SpvFacilityMember2023-12-122023-12-120001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:SouthernOrthodonticsPartnersManagementLlcMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberus-gaap:InvestmentUnaffiliatedIssuerMember2024-12-310001932591ck0001932591:SlrCapitalManagementLlcMemberck0001932591:PostExchangeListingAdministrationExpensesMember2025-04-012025-06-300001932591ck0001932591:WorldInsuranceAssociatesLlcMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591ck0001932591:SpreadOneMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | UVP Management, LLC | Health Care Providers & Services | S+625 | 1.00% | 10.73% | 9/2023 | 9/20252024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Western Veterinary Partners LLC | Diversified Consumer Services | S+500 | 1.00% | 9.33% | 1/2024 | 10/20272024-01-012024-12-3100019325912024-01-012024-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Sherwood Management Co., Inc. | Specialty Retail | S+500 | 2.00% | 9.59% | 3/2025 | 3/20302025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Eyesouth Eye Care Holdco LLC | Health Care Providers & Services | S+550 | 1.00% | 10.15% | 4/2024 | 10/20292024-01-012024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:HealthCareEquipmentAndSuppliesMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Legacy Service Partners, LLC | Diversified Consumer Services | S+525 | 1.00% | 9.73% | 3/2024 | 1/20292024-12-310001932591ck0001932591:Wilbur-EllisHoldingsIILLCMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-3000019325912024-03-310001932591ck0001932591:NexusIntermediateIiiLlcMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591ck0001932591:SubscriptionFacilityMember2023-03-202023-03-200001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:UnitedDigestiveMsoParentLlcMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Sherwood Management Co., Inc. | Specialty Retail | S+500 | 2.00% | 9.59% | 3/2025 | 3/20302025-01-012025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:PersonalCareProductsMember2025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:BiotechnologyMember2025-06-300001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:ArdelyxInc.Member2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:CommercialServicesSuppliesMember2025-06-300001932591ck0001932591:WesternVeterinaryPartnersLlcMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:PlasticManagementLlcMember2024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:FoundationConsumerBrandsLlcMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Quantcast Corporation | Commercial Services & Supplies | S+525 | 2.00% | 11.75% | 6/2024 | 6/20292024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Peter C. Foy & Associates Insurance Services, LLC | Insurance | S+650 | 0.75% | 10.86% | 7/2023 | 11/20282024-12-310001932591ck0001932591:SubscriptionFacilityMember2023-03-200001932591Bank Debt/Senior Secured Loans — 259.9%| World Insurance Associates, LLC | Insurance | S+500 | 1.00% | 9.30% | 10/2023 | 4/20302025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | OIS Management Services, LLC | Health Care Providers & Services | S+475 | 0.75% | 9.08% | 12/2023 | 11/20282024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | United Digestive MSO Parent, LLC | Health Care Providers & Services | S+575 | 1.00% | 10.08% | 3/2023 | 3/20292024-01-012024-12-3100019325912023-12-310001932591ck0001932591:SpvFacilityMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Nexus Intermediate III, LLC | Professional Services | S+475 | 0.75% | 9.10% | 8/2024 | 12/20272024-12-310001932591us-gaap:FairValueInputsLevel3Member2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Cerapedics, Inc. | Biotechnology | S+620 | 2.75% | 10.52% | 10/2023 | 1/20282025-06-300001932591us-gaap:FairValueInputsLevel1Member2025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:PinnacleFertilityIncMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Alkeme Intermediary Holdings, LLC | Insurance | S+525 | 1.00% | 9.55% | 9/2023 | 10/20262025-06-300001932591us-gaap:FairValueInputsLevel2Member2025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:DiversifiedConsumerServicesMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | ONS MSO, LLC | Health Care Providers & Services | S+575 | 1.00% | 10.03% | 4/2024 | 7/20282025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | WCI-BXC Purchaser, LLC | Distributors | S+625 | 0.75% | 10.78% | 11/2023 | 11/20302024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | World Insurance Associates, LLC | Insurance | S+575 | 1.00% | 10.08% | 10/2023 | 4/20282024-01-012024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:PlasticManagementLlcMember2025-06-3000019325912023-02-012023-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:OisManagementServicesLlcMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Pinnacle Fertility, Inc. | Health Care Providers & Services | S+500 | 0.75% | 9.51% | 3/2025 | 3/20282025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Cerapedics, Inc. | Biotechnology | S+620 | 2.75% | 10.52% | 10/2023 | 1/20282025-01-012025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:InsuranceMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Centinel Spine, LLC | Health Care Equipment & Supplies | S+530 | 4.35% | 9.65% | 2/2025 | 3/20302025-06-300001932591ck0001932591:CogentBiosciencesIncMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2025-01-012025-06-300001932591us-gaap:FairValueInputsLevel2Memberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591us-gaap:FairValueInputsLevel2Memberck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Wilbur-Ellis Holdings II, LLC| Fertilizer & Agricultural Chemicals| S+400| 1.00% | 8.32%| 6/2025 | 6/20302025-06-300001932591ck0001932591:SlrCapitalManagementLlcMemberck0001932591:PostExchangeListingAdministrationExpensesMember2024-04-012024-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Cerapedics, Inc. | Biotechnology | S+620 | 2.75% | 10.72% | 10/2023 | 1/20282024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Ardelyx, Inc. | Pharmaceuticals | S+400 | 4.70% | 8.70% | 3/2024 | 7/20282024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | ONS MSO, LLC | Health Care Providers & Services | S+575 | 1.00% | 10.34% | 4/2024 | 7/20262024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Foundation Consumer Brands, LLC | Personal Care Products | S+500 | 1.00% | 9.36% | 1/2025 | 2/20292025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Exactcare Parent, Inc. | Health Care Providers & Services | S+550 | 1.00% | 10.03% | 11/2023 | 11/20292024-01-012024-12-310001932591srt:WeightedAverageMember2024-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:LegacyServicePartnersLlcMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Nexus Intermediate III, LLC | Professional Services | S+475 | 0.75% | 9.10% | 8/2024 | 12/20272024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Foundation Consumer Brands, LLC | Personal Care Products | S+500 | 1.00% | 9.36% | 1/2025 | 2/20292025-06-300001932591ck0001932591:SubscriptionFacilityMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Alkeme Intermediary Holdings, LLC | Insurance | S+575 | 1.00% | 10.08% | 9/2023 | 10/20262024-01-012024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:SherwoodManagementCoIncMember2025-06-300001932591us-gaap:FairValueInputsLevel1Memberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Alkeme Intermediary Holdings, LLC | Insurance | S+525 | 1.00% | 9.55% | 9/2023 | 10/20262025-01-012025-06-300001932591ck0001932591:SlrCapitalManagementLlcMemberck0001932591:PostExchangeListingAdministrationExpensesMember2024-01-012024-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Crewline Buyer, Inc. | IT Services | S+675 | 1.00% | 11.11% | 11/2023 | 11/20302024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | ONS MSO, LLC | Health Care Providers & Services | S+575 | 1.00% | 10.34% | 4/2024 | 7/20262024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Wilbur-Ellis Holdings II, LLC| Fertilizer & Agricultural Chemicals| S+400| 1.00% | 8.32%| 6/2025 | 6/20302025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | CVAUSA Management, LLC | Health Care Providers & Services | S+525 | 1.00% | 9.56% | 5/2023 | 5/20292025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | United Digestive MSO Parent, LLC | Health Care Providers & Services | S+575 | 1.00% | 10.08% | 3/2023 | 3/20292024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberus-gaap:InvestmentUnaffiliatedIssuerMember2025-06-300001932591ck0001932591:NonControlledNonAffiliatedInvestmentsMember2025-04-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Human Interest, Inc. | Professional Services | S+625 | 1.00% | 10.57% | 9/2024 | 7/20272025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Pasadena Private Lending Inc. | Diversified Financial Service | S+750 | 1.00% | 11.88% | 12/2024 | 4/20282024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Exactcare Parent, Inc. | Health Care Providers & Services | S+550 | 1.00% | 9.76% | 11/2023 | 11/20292025-01-012025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:TheTownsendCompanyLlcMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Accession Risk Management Group, Inc. | Insurance | S+475 | 0.75% | 9.03% | 12/2023 | 11/20292025-01-012025-06-300001932591ck0001932591:SlrCapitalManagementLlcMemberck0001932591:PostExchangeListingAdministrationExpensesMember2025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Legacy Service Partners, LLC | Diversified Consumer Services | S+525 | 1.00% | 9.70% | 3/2024 | 1/20292025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | CVAUSA Management, LLC | Health Care Providers & Services | S+650 | 1.00% | 10.84% | 5/2023 | 5/20292024-12-310001932591ck0001932591:WesternVeterinaryPartnersLlcMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Ardelyx, Inc. | Pharmaceuticals | S+400 | 4.70% | 8.70% | 3/2024 | 7/20282024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:DiversifiedConsumerServicesMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Eyesouth Eye Care Holdco LLC | Health Care Providers & Services | S+550 | 1.00% | 10.15% | 4/2024 | 10/20292024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:SprTherapeuticsIncMember2025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:ConsumerStaplesDistributionAndRetailMember2025-06-300001932591ck0001932591:InternetSoftwareAndServicesMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMember2025-03-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:ExactcareParentIncMember2024-12-310001932591ck0001932591:QuantcastCorporationMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Crewline Buyer, Inc. | IT Services | S+675 | 1.00% | 11.11% | 11/2023 | 11/20302024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Medrina, LLC | Health Care Providers & Services | S+600 | 1.00% | 10.44% | 10/2023 | 10/20292024-01-012024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:OisManagementServicesLlcMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | MRI Software, LLC | Software | S+475 | 1.00% | 9.08% | 12/2023 | 2/20272024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Accession Risk Management Group, Inc. | Insurance | S+475 | 0.75% | 9.03% | 12/2023 | 11/20292025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+550 | 1.00% | 9.80% | 5/2024 | 7/20262025-01-012025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | AAH Topco., LLC | Diversified Consumer Services | S+525 | 0.75% | 9.67% | 1/2024 | 12/20272025-01-012025-06-3000019325912024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | CVAUSA Management, LLC | Health Care Providers & Services | S+650 | 1.00% | 10.84% | 5/2023 | 5/20292024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Pinnacle Fertility, Inc. | Health Care Providers & Services | S+500 | 0.75% | 9.51% | 3/2025 | 3/20282025-01-012025-06-300001932591ck0001932591:SpreadTwoMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:DistributorsMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Legacy Service Partners, LLC | Diversified Consumer Services | S+525 | 1.00% | 9.70% | 3/2024 | 1/20292025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:CommercialServicesSuppliesMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:HealthCareTechnologyMember2025-06-3000019325912025-06-3000019325912024-01-012024-12-310001932591ck0001932591:NexusIntermediateIiiLlcMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Western Veterinary Partners LLC | Diversified Consumer Services | S+500 | 1.00% | 9.33% | 1/2024 | 10/20272024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:CvausaManagementLlcMember2024-12-310001932591ck0001932591:CrewlineBuyerIncMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:MriSoftwareLlcMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9%| World Insurance Associates, LLC | Insurance | S+500 | 1.00% | 9.30% | 10/2023 | 4/20302025-01-012025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:LegacyServicePartnersLlcMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Quantcast Corporation | Commercial Services & Supplies | S+525 | 2.00% | 11.58% | 6/2024 | 6/20292025-01-012025-06-300001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMembersrt:MinimumMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberus-gaap:FinancialServicesSectorMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Medrina, LLC | Health Care Providers & Services | S+600 | 1.00% | 10.13% | 10/2023 | 10/20292025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Eyesouth Eye Care Holdco LLC | Health Care Providers & Services | S+550 | 1.00% | 9.92% | 4/2024 | 10/20292025-06-300001932591ck0001932591:Wilbur-EllisHoldingsIILLCMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMember2025-01-012025-06-300001932591ck0001932591:ArcutisBiotherapeticsIncMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | WCI-BXC Purchaser, LLC | Distributors | S+625 | 0.75% | 10.78% | 11/2023 | 11/20302024-12-310001932591us-gaap:FairValueInputsLevel3Memberck0001932591:MarketYieldMemberck0001932591:BankDebtAndSeniorSecuredLoansMember2024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | MRI Software, LLC | Software | S+475 | 1.00% | 9.08% | 12/2023 | 2/20272024-01-012024-12-310001932591ck0001932591:StellaChewysLLCMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:SoftwareMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | United Digestive MSO Parent, LLC | Health Care Providers & Services | S+575 | 1.00% | 10.04% | 3/2023 | 3/20292025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:InsuranceMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Western Veterinary Partners LLC | Diversified Consumer Services | S+525 | 1.00% | 9.31% | 1/2024 | 10/20272025-06-300001932591srt:WeightedAverageMember2025-06-300001932591ck0001932591:AahTopcoLlcMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:WciBxcPurchaserLlcMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:FertilizerAgriculturalChemicalsMember2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Quantcast Corporation | Commercial Services & Supplies | S+525 | 2.00% | 11.58% | 6/2024 | 6/20292025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:DistributorsMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Accession Risk Management Group, Inc. | Insurance | S+475 | 0.75% | 9.08% | 12/2023 | 11/20292024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Human Interest, Inc. | Professional Services | S+625 | 1.00% | 10.57% | 9/2024 | 7/20272025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | OIS Management Services, LLC | Health Care Providers & Services | S+475 | 0.75% | 9.01% | 12/2023 | 11/20282025-01-012025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:ArdelyxInc.Member2025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Crewline Buyer, Inc. | IT Services | S+675 | 1.00% | 11.08% | 11/2023 | 11/20302025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Pasadena Private Lending Inc | Financial Services | S+750 | 1.00% | 11.82% | 12/2024 | 4/20282025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Outset Medical, Inc. | Health Care Equipment & Supplies | S+515 | 2.75% | 9.67% | 1/2024 | 11/20272024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Nexus Intermediate III, LLC | Professional Services | S+475 | 0.75% | 8.97% | 8/2024 | 12/20272025-01-012025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Retina Midco, Inc. | Health Care Providers & Services | S+575 | 1.00% | 10.35% | 12/2023 | 1/20262024-01-012024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | SPR Therapeutics, Inc. | Health Care Technology | S+515 | 4.00% | 9.67% | 1/2024 | 2/20292024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Nexus Intermediate III, LLC | Professional Services | S+475 | 0.75% | 8.97% | 8/2024 | 12/20272025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:BiotechnologyMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | Retina Midco, Inc. | Health Care Providers & Services | S+575 | 1.00% | 10.35% | 12/2023 | 1/20262024-12-3100019325912025-03-310001932591ck0001932591:SpvFacilityMember2024-12-310001932591ck0001932591:WorldInsuranceAssociatesLlcMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591ck0001932591:CerapedicsInc.Memberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591ck0001932591:SherwoodManagementCoIncMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2024-12-310001932591ck0001932591:BankDebtAndSeniorSecuredLoansMember2024-12-310001932591ck0001932591:QuantcastCorporationMemberck0001932591:UnfundedDebtAndEquityCommitmentsMember2025-06-300001932591Bank Debt/Senior Secured Loans — 241.8% | Accession Risk Management Group, Inc. | Insurance | S+475 | 0.75% | 9.08% | 12/2023 | 11/20292024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | Centinel Spine, LLC | Health Care Equipment & Supplies | S+530 | 4.35% | 9.65% | 2/2025 | 3/20302025-01-012025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:TheTownsendCompanyLlcMember2024-12-310001932591Bank Debt/Senior Secured Loans — 241.8% | SPR Therapeutics, Inc. | Health Care Technology | S+515 | 4.00% | 9.67% | 1/2024 | 2/20292024-01-012024-12-310001932591us-gaap:InvestmentUnaffiliatedIssuerMember2024-12-310001932591Bank Debt/Senior Secured Loans — 259.9% | CVAUSA Management, LLC | Health Care Providers & Services | S+525 | 1.00% | 9.56% | 5/2023 | 5/20292025-06-300001932591Bank Debt/Senior Secured Loans — 259.9% | Eyesouth Eye Care Holdco LLC | Health Care Providers & Services | S+550 | 1.00% | 9.92% | 4/2024 | 10/20292025-01-012025-06-300001932591ck0001932591:BankDebtAndSeniorSecuredLoansMemberck0001932591:ItServicesMember2024-12-310001932591us-gaap:FairValueInputsLevel1Memberck0001932591:BankDebtAndSeniorSecuredLoansMember2025-06-300001932591us-gaap:FairValueInputsLevel2Member2024-12-310001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:CvausaManagementLlcMember2025-06-300001932591ck0001932591:UnfundedDebtAndEquityCommitmentsMemberck0001932591:PasadenaPrivateLendingIncMember2025-06-30xbrli:pureiso4217:USDxbrli:sharesxbrli:sharesck0001932591:Productiso4217:USD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarter Ended June 30, 2025

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 814-01616

SLR Private Credit BDC II LLC

(Exact name of registrant as specified in its charter)


Delaware	88-1890628
(State of Incorporation)	(I.R.S. Employer Identification No.)

500 Park Avenue New York, N.Y.	10022
(Address of principal executive offices)	(Zip Code)

(212) 993-1670

(Registrant’s telephone number, including area code)

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

     Title of Each Class
 
     Trading
Symbol
 
     Name of Each Exchange
on Which Registered

     N/A

     N/A

     N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes☒ No☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☐	Accelerated filer	☐

Non-accelerated filer	☒	Smaller reporting company	☐

Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐ No☒

As of June 30, 2025, there was no established public market for the registrant’s units. The issuer had 981,403 units outstanding as of August 1, 2025.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2025

TABLE OF CONTENTS


	Index	Page No.
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements
	Consolidated Statements of Assets and Liabilities as of June 30, 2025 (unaudited) and December 31, 2024	3
	Consolidated Statements of Operations for the three and six months ended June 30, 2025 (unaudited) and the three and six months ended June 30, 2024 (unaudited)	4
	Consolidated Statements of Changes in Unitholders’ Capital for the three and six months ended June 30, 2025 (unaudited) and the three and six months ended June 30, 2024 (unaudited)	5
	Consolidated Statements of Cash Flows for the six months ended June 30, 2025 (unaudited) and the six months ended June 30, 2024 (unaudited)	6
	Consolidated Schedule of Investments as of June 30, 2025 (unaudited)	7
	Consolidated Schedule of Investments as of December 31, 2024	10
	Notes to Consolidated Financial Statements (unaudited)	12
	Report of Independent Registered Public Accounting Firm	30
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	31
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	42
Item 4.	Controls and Procedures	42
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	43
Item 1A.	Risk Factors	43
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	43
Item 3.	Defaults Upon Senior Securities	43
Item 4.	Mine Safety Disclosures	43
Item 5.	Other Information	43
Item 6.	Exhibits	44
SIGNATURES		45

Table of Contents

PART I. FINANCIAL INFORMATION

In this Quarterly Report, “Company”, “we”, “us”, and “our” refer to SLR Private Credit BDC II LLC unless the context states otherwise.

Item 1. Financial Statements

SLR PRIVATE CREDIT BDC II LLC

Consolidated Statements of Assets and Liabilities

(in thousands, except unit and per unit amounts)


	June 30, 2025 (unaudited)		December 31, 2024
Assets
Investments at fair value:
Non-controlled/non-affiliated investments (cost: $41,070 and $37,628, respectively)	$	41,597	$	38,271
Cash		1,157		1,363
Interest receivable		280		213
Receivable for investments sold		9		—
Prepaid expenses		13		2
Total assets	$	43,056	$	39,849
Liabilities
Revolving credit facility due December 2028 (the “SPV Facility”) ($15,000 and $16,250 face amounts, respectively, reported net of unamortized debt issuance costs of $339 and $379, respectively. See note 5)	$	14,661	$	15,871
Revolving credit facility due March 2026 (the “Subscription Facility”) ($11,700 and $6,700 face amounts, respectively, reported net of unamortized debt issuance costs of $69 and $55, respectively. See note 5)		11,631		6,645
Distributions payable		—		309
Management fee payable (see note 3)		176		364
Administration fee payable (see note 3)		8		8
Interest payable (see note 5)		366		333
Other liabilities and accrued expenses		210		489
Total liabilities	$	27,052	$	24,019
Commitments and contingencies (see note 6)
Unitholders’ Capital
Common Unitholders’ capital (981,403 and 981,403 units, respectively, issued and outstanding)		15,932		15,932
Accumulated distributable net earnings (loss)		72		(102	)
Total unitholders’ capital	$	16,004	$	15,830
Total liabilities and unitholders’ capital	$	43,056	$	39,849
Net asset value per unit	$	16.31	$	16.13

See notes to consolidated financial statements.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Consolidated Statements of Operations (unaudited)

(in thousands, except unit and per unit amounts)


	Three months ended				Six months ended
	June 30, 2025		June 30, 2024		June 30, 2025			June 30, 2024
Investment Income:
Interest income from non-controlled/non-affiliated investments	$	1,028	$	990	$	2,161		$	1,837
Other income from non-controlled/non-affiliated investments		17		70		25			91
Total investment income		1,045		1,060		2,186			1,928
Expenses:
Management fees (see note 3)	$	106	$	106	$	192		$	201
Administration fees (see note 3)		8		6		15			11
Interest and other credit facility expenses (see note 5)		535		573		1,081			1,083
Other general and administrative expenses		140		138		274			320
Total expenses		789		823		1,562			1,615
Net investment income	$	256	$	237	$	624		$	313
Realized and unrealized gain (loss) on investments and cash equivalents:
Net realized gain (loss) on non-controlled/non-affiliated investments and cash equivalents	$	—	$	—	$	—		$	(1	)
Net change in unrealized gain (loss) on non-controlled/non-affiliated investments and cash equivalents		64		100		(116	)		221
Net realized and unrealized gain (loss) on non-controlled/non-affiliated investments and cash equivalents		64		100		(116	)		220
Net Increase in Unitholders’ Capital Resulting From Operations	$	320	$	337	$	508		$	533
Net Income Per Unit	$	0.33	$	0.48	$	0.52		$	0.81

See notes to consolidated financial statements.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Consolidated Statements of Changes in Unitholders’ Capital (unaudited)

(in thousands, except unit amounts)


	Three months ended						Six months ended
	June 30, 2025			June 30, 2024			June 30, 2025			June 30, 2024
Increase (decrease) in unitholders’ capital resulting from operations:
Net investment income	$	256		$	237		$	624		$	313
Net realized gain (loss)		—			—			—			(1	)
Net change in unrealized gain (loss)		64			100			(116	)		221
Net increase in unitholders’ capital resulting from operations		320			337			508			533
Distributions to unitholders:
From distributable earnings		(334	)		(163	)		(334	)		(293	)
From return of capital		—			—			—			—
Net distributions to unitholders		(334	)		(163	)		(334	)		(293	)
Increase in unitholders’ capital resulting from capital activity:
Contributions		—			4,000			—			5,500
Net increase in unitholders’ capital resulting from capital activity		—			4,000			—			5,500
Total increase (decrease) in unitholders’ capital		(14	)		4,174			174			5,740
Unitholders’ capital, beginning of period		16,018			10,201			15,830			8,635
Unitholders’ capital, end of period	$	16,004		$	14,375		$	16,004		$	14,375
Capital unit activity (see note 7):
Units issued		—			254,939			—			350,541
Net increase from capital unit activity		—			254,939			—			350,541

See notes to consolidated financial statements.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Consolidated Statements of Cash Flows (unaudited)

(in thousands)


	Six months ended
	June 30, 2025			June 30, 2024
Cash Flows from Operating Activities:
Net increase in unitholders’ capital resulting from operations	$	508		$	533
Adjustments to reconcile net increase in unitholders’ capital resulting from operations to net cash used in operating activities:
Net realized (gain) loss on investments and cash equivalents		—			1
Net change in unrealized (gain) loss on investments		116			(221	)
Deferred financing costs		171			197
Net accretion of discount on investments		(104	)		(75	)
(Increase) decrease in operating assets:
Purchase of investments		(11,490	)		(16,515	)
Proceeds from disposition of investments		8,152			3,589
Capitalization of payment-in-kind income		—			(14	)
Interest receivable		(67	)		(85	)
Receivable for investments sold		(9	)		(2	)
Prepaid expenses		(11	)		(7	)
Increase (decrease) in operating liabilities:
Payable for cash equivalents purchased		—			(4,960	)
Management fee payable		(188	)		151
Administration fee payable		—			3
Interest payable		33			180
Other liabilities and accrued expenses		(279	)		(24	)
Net Cash Used in Operating Activities		(3,168	)		(17,249	)
Cash Flows from Financing Activities:
Contributions from unitholders		—			5,500
Cash distributions paid		(643	)		(293	)
Proceeds from borrowings		11,605			16,381
Repayments of borrowings		(8,000	)		(8,600	)
Net Cash Provided by Financing Activities		2,962			12,988
NET DECREASE IN CASH AND CASH EQUIVALENTS		(206	)		(4,261	)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		1,363			5,283
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	1,157		$	1,022
Supplemental disclosure of cash flow information:
Cash paid for interest	$	877		$	706

See notes to consolidated financial statements.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Consolidated Schedule of Investments (unaudited)

June 30, 2025

(in thousands, except share/unit amounts)


Description	Industry	Spread above Index (2)	Floor			Interest Rate (1)			Acquisition Date	Maturity Date	Par Amount		Cost		Fair Value
Bank Debt/Senior Secured Loans — 259.9%
AAH Topco., LLC(4)	Diversified Consumer Services	S+525		0.75	%		9.67	%	1/2024	12/2027	$	1,790	$	1,761	$	1,790
Accession Risk Management Group, Inc.(4)	Insurance	S+475		0.75	%		9.03	%	12/2023	11/2029		1,579		1,574		1,579
Alkeme Intermediary Holdings, LLC(4)	Insurance	S+525		1.00	%		9.55	%	9/2023	10/2026		2,281		2,249		2,281
Ardelyx, Inc.(4)(5)	Pharmaceuticals	S+400(6)		4.70	%		8.70	%	3/2024	7/2028		3,190		3,198		3,230
Centinel Spine, LLC	Health Care Equipment & Supplies	S+530		4.35	%		9.65	%	2/2025	3/2030		695		691		708
Cerapedics, Inc.(4)	Biotechnology	S+620		2.75	%		10.52	%	10/2023	1/2028		1,276		1,290		1,289
Cogent Biosciences, Inc.(5)	Biotechnology	S+475		4.15	%		9.06	%	6/2025	6/2030		579		575		575
Crewline Buyer, Inc.(4)	IT Services	S+675		1.00	%		11.08	%	11/2023	11/2030		1,171		1,147		1,171
CVAUSA Management, LLC(4)	Health Care Providers & Services	S+525		1.00	%		9.56	%	5/2023	5/2029		2,111		2,065		2,111
Exactcare Parent, Inc.(4)	Health Care Providers & Services	S+550		1.00	%		9.76	%	11/2023	11/2029		734		718		734
Eyesouth Eye Care Holdco LLC(4)	Health Care Providers & Services	S+550		1.00	%		9.92	%	4/2024	10/2029		606		596		606
FE Advance, LLC & Sonic ACA Advance LLC(4)	Financial Services	S+650		1.00	%		10.83	%	7/2024	7/2027		1,438		1,416		1,438
Foundation Consumer Brands, LLC(4)	Personal Care Products	S+500		1.00	%		9.36	%	1/2025	2/2029		1,346		1,339		1,346
Human Interest, Inc.(4)	Professional Services	S+625		1.00	%		10.57	%	9/2024	7/2027		1,032		1,014		1,032
Legacy Service Partners, LLC	Diversified Consumer Services	S+525		1.00	%		9.70	%	3/2024	1/2029		641		628		641
Medrina, LLC(4)	Health Care Providers & Services	S+600		1.00	%		10.13	%	10/2023	10/2029		639		626		639
MRI Software, LLC(4)	Software	S+475		1.00	%		9.05	%	12/2023	2/2027		1,570		1,569		1,570
Nexus Intermediate III, LLC	Professional Services	S+475		0.75	%		8.97	%	8/2024	12/2027		239		236		239
OIS Management Services, LLC(4)	Health Care Providers & Services	S+475		0.75	%		9.01	%	12/2023	11/2028		2,211		2,183		2,211
ONS MSO, LLC(4)	Health Care Providers & Services	S+575		1.00	%		10.03	%	4/2024	7/2028		1,494		1,483		1,494
Pasadena Private Lending Inc.(5)	Financial Services	S+750		1.00	%		11.82	%	12/2024	4/2028		591		585		591
Pinnacle Fertility, Inc.	Health Care Providers & Services	S+500		0.75	%		9.51	%	3/2025	3/2028		748		720		748
Quantcast Corporation(4)	Commercial Services & Supplies	S+525		2.00	%		11.58	%	6/2024	6/2029		594		588		594
Sherwood Management Co., Inc.	Specialty Retail	S+500		2.00	%		9.59	%	3/2025	3/2030		346		342		346
Southern Orthodontic Partners Management, LLC(4)	Health Care Providers & Services	S+550		1.00	%		9.80	%	5/2024	7/2026		1,074		1,067		1,074
SPR Therapeutics, Inc.(4)	Health Care Technology	S+515		4.00	%		9.47	%	1/2024	2/2029		598		600		621
Stella & Chewy's LLC	Consumer Staples Distribution & Retail	S+525		2.00	%		9.58	%	3/2025	3/2028		535		527		535
The Townsend Company, LLC(4)	Commercial Services & Supplies	S+500		1.00	%		9.30	%	8/2023	8/2030		1,459		1,426		1,459
United Digestive MSO Parent, LLC(4)	Health Care Providers & Services	S+575		1.00	%		10.04	%	3/2023	3/2029		716		700		716
UVP Management, LLC(4)	Health Care Providers & Services	S+550		1.00	%		9.95	%	9/2023	9/2027		758		746		758
WALCO Funding, LLC	Financial Services	S+785		1.00	%		12.18	%	6/2025	12/2028		946		930		929
WCI-BXC Purchaser, LLC(4)	Distributors	S+625		0.75	%		10.51	%	11/2023	11/2030		659		645		659
Western Veterinary Partners LLC(4)	Diversified Consumer Services	S+525		1.00	%		9.31	%	1/2024	10/2027		2,812		2,780		2,812
Wilbur-Ellis Holdings II, LLC	Fertilizer & Agricultural Chemicals	S+400		1.00	%		8.32	%	6/2025	6/2030		1,096		1,080		1,080
World Insurance Associates, LLC(4)	Insurance	S+500		1.00	%		9.30	%	10/2023	4/2030		1,991		1,976		1,991
Total Bank Debt/Senior Secured Loans													$	41,070	$	41,597
Total Investments(3)— 259.9%													$	41,070	$	41,597
Liabilities in Excess of Other Assets — (159.9%)																(25,593	)
Net Assets — 100.0%															$	16,004

See notes to consolidated financial statements.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Consolidated Schedule of Investments (unaudited) (continued)

June 30, 2025

(in thousands, except share/unit amounts)

(1)

Floating rate debt investments typically bear interest at a rate determined by reference to either the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, the Company has provided the current interest rate in effect as of June 30, 2025.

(2)

Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor.

(3)

Aggregate net unrealized depreciation for U.S. federal income tax purposes is $124; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $528 and $652, respectively, based on a tax cost of $41,721. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

(4)

Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SLR Private Credit BDC II SPV LLC (the “SPV”). Such investments are pledged as collateral under the SPV Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.

(5)

Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (the “1940 Act”). If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of June 30, 2025, on a fair value basis, non-qualifying assets in our portfolio represented 10.2% of the total assets of the Company.

(6)

Certain tranches have a spread of S+400 and certain tranches have a spread of S+425.

See notes to consolidated financial statements.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Consolidated Schedule of Investments (unaudited) (continued)

June 30, 2025

(in thousands, except share/unit amounts)


Industry Classification	Percentage of Total Investments (at fair value) as of June 30, 2025
Health Care Providers & Services		26.7	%
Insurance		14.1	%
Diversified Consumer Services		12.6	%
Pharmaceuticals		7.8	%
Financial Services		7.1	%
Commercial Services & Supplies		4.9	%
Biotechnology		4.5	%
Software		3.8	%
Personal Care Products		3.2	%
Professional Services		3.0	%
IT Services		2.8	%
Fertilizer & Agricultural Chemicals		2.6	%
Health Care Equipment & Supplies		1.7	%
Distributors		1.6	%
Health Care Technology		1.5	%
Consumer Staples Distribution & Retail		1.3	%
Specialty Retail		0.8	%
Total Investments		100.0	%

See notes to consolidated financial statements.

Table of Contents

SLR Private Credit BDC II LLC

Consolidated Schedule of Investments

December 31, 2024

(in thousands, except share/unit amounts)


Description	Industry	Spread above Index (2)	Floor			Interest Rate (1)			Acquisition Date	Maturity Date	Par Amount		Cost		Fair Value
Bank Debt/Senior Secured Loans — 241.8%
AAH Topco., LLC(4)	Diversified Consumer Services	S+525		0.75	%		9.71	%	1/2024	12/2027	$	1,212	$	1,190	$	1,212
Accession Risk Management Group, Inc.(4)	Insurance	S+475		0.75	%		9.08	%	12/2023	11/2029		1,587		1,582		1,587
Alkeme Intermediary Holdings, LLC(4)	Insurance	S+575		1.00	%		10.08	%	9/2023	10/2026		2,293		2,249		2,293
Ardelyx, Inc.(4)(5)	Pharmaceuticals	S+400(6)		4.70	%		8.70	%	3/2024	7/2028		1,970		1,971		1,995
Cerapedics, Inc.(4)	Biotechnology	S+620		2.75	%		10.72	%	10/2023	1/2028		1,276		1,285		1,289
Crewline Buyer, Inc.(4)	IT Services	S+675		1.00	%		11.11	%	11/2023	11/2030		1,171		1,145		1,171
CVAUSA Management, LLC(4)	Health Care Providers & Services	S+650		1.00	%		10.84	%	5/2023	5/2029		1,172		1,143		1,172
Exactcare Parent, Inc.(4)	Health Care Providers & Services	S+550		1.00	%		10.03	%	11/2023	11/2029		738		721		738
Eyesouth Eye Care Holdco LLC(4)	Health Care Providers & Services	S+550		1.00	%		10.15	%	4/2024	10/2029		609		599		609
FE Advance, LLC(4)	Diversified Financial Services	S+650		1.00	%		10.86	%	7/2024	7/2027		1,438		1,412		1,438
Human Interest, Inc.(4)	Internet Software & Services	S+735		1.00	%		11.90	%	9/2024	7/2027		1,032		1,006		1,032
Legacy Service Partners, LLC	Diversified Consumer Services	S+525		1.00	%		9.73	%	3/2024	1/2029		644		630		644
Medrina, LLC(4)	Health Care Providers & Services	S+600		1.00	%		10.44	%	10/2023	10/2029		550		538		550
MRI Software, LLC(4)	Software	S+475		1.00	%		9.08	%	12/2023	2/2027		1,578		1,576		1,578
Nexus Intermediate III, LLC	Professional Services	S+475		0.75	%		9.10	%	8/2024	12/2027		240		237		240
OIS Management Services, LLC(4)	Health Care Providers & Services	S+475		0.75	%		9.08	%	12/2023	11/2028		2,171		2,140		2,171
ONS MSO, LLC(4)	Health Care Providers & Services	S+575		1.00	%		10.34	%	4/2024	7/2026		1,502		1,491		1,502
Outset Medical, Inc.(4)	Health Care Equipment & Supplies	S+515		2.75	%		9.67	%	1/2024	11/2027		3,113		3,133		3,230
Pasadena Private Lending Inc.(5)	Diversified Financial Services	S+750		1.00	%		11.88	%	12/2024	4/2028		456		450		450
Peter C. Foy & Associates Insurance Services, LLC(4)	Insurance	S+650		0.75	%		10.86	%	7/2023	11/2028		373		367		373
Quantcast Corporation(4)	Commercial Services & Supplies	S+525		2.00	%		11.75	%	6/2024	6/2029		727		718		727
Retina Midco, Inc.(4)	Health Care Providers & Services	S+575		1.00	%		10.35	%	12/2023	1/2026		3,051		3,016		3,112
Southern Orthodontic Partners Management, LLC(4)	Health Care Providers & Services	S+525		1.00	%		9.58	%	5/2024	7/2026		721		715		721
SPR Therapeutics, Inc.(4)	Health Care Technology	S+515		4.00	%		9.67	%	1/2024	2/2029		399		399		412
The Townsend Company, LLC(4)	Commercial Services & Supplies	S+500		1.00	%		9.36	%	8/2023	8/2030		1,382		1,348		1,369
United Digestive MSO Parent, LLC(4)	Health Care Providers & Services	S+575		1.00	%		10.08	%	3/2023	3/2029		696		680		696
UVP Management, LLC(4)	Health Care Providers & Services	S+625		1.00	%		10.73	%	9/2023	9/2025		1,119		1,108		1,119
WCI-BXC Purchaser, LLC(4)	Distributors	S+625		0.75	%		10.78	%	11/2023	11/2030		662		648		662
Western Veterinary Partners LLC(4)	Diversified Consumer Services	S+500		1.00	%		9.33	%	1/2024	10/2027		2,437		2,405		2,437
World Insurance Associates, LLC(4)	Insurance	S+575		1.00	%		10.08	%	10/2023	4/2028		1,742		1,726		1,742
Total Bank Debt/Senior Secured Loans													$	37,628	$	38,271
Total Investments(3)— 241.8%													$	37,628	$	38,271
Liabilities in Excess of Other Assets — (141.8%)																(22,441	)
Net Assets — 100.0%															$	15,830

(1)

Floating rate debt investments typically bear interest at a rate determined by reference to either the Secured Overnight Financing Rate or the prime index rate, and which typically reset monthly, quarterly or semi-annually. For each debt investment the Company has provided the current interest rate in effect as of December 31, 2024.

See notes to consolidated financial statements.

Table of Contents

SLR Private Credit BDC II LLC

Consolidated Schedule of Investments (continued)

December 31, 2024

(in thousands, except share/unit amounts)

(2)

Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor.

(3)

Aggregate net unrealized depreciation for U.S. federal income tax purposes is $8; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $643 and $651, respectively, based on a tax cost of $38,279. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act. These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

(4)

Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SLR Private Credit BDC II SPV LLC. Such investments are pledged as collateral under the SPV Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.

(5)

Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2024, on a fair value basis, non-qualifying assets in our portfolio represented 6.1% of the total assets of the Company.

(6)

Certain tranches have a spread of S+400 and certain tranches have a spread of S+425.


Industry Classification	Percentage of Total Investments (at fair value) as of December 31, 2024
Health Care Providers & Services		32.4	%
Insurance		15.7	%
Diversified Consumer Services		11.2	%
Health Care Equipment & Supplies		8.4	%
Commercial Services & Supplies		5.5	%
Pharmaceuticals		5.2	%
Diversified Financial Services		4.9	%
Software		4.1	%
Biotechnology		3.4	%
IT Services		3.1	%
Internet Software & Services		2.7	%
Distributors		1.7	%
Health Care Technology		1.1	%
Professional Services		0.6	%
Total Investments		100.0	%

See notes to consolidated financial statements.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Notes to Consolidated Financial Statements (unaudited)

June 30, 2025

(in thousands, except unit and per unit amounts)

Note 1. Organization

SLR Private Credit BDC II LLC (the “Company”, “we”, “us” or “our”) was formed as a limited liability company under the laws of the State of Delaware on April 18, 2022 as an externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it applies the guidance in the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). As a BDC and a RIC, the Company is required to comply with certain regulatory requirements. The Company was formed primarily to provide investors with attractive long-term returns through investments made pursuant to the investment strategy of the Company described below. SLR Capital Partners, LLC (the “Adviser” or “SLR”) serves as the Company’s investment adviser pursuant to an investment management agreement with the Company (as amended, restated or otherwise modified from time to time, the “Investment Management Agreement”). The fiscal year end of the Company is December 31.

In connection with the Company’s formation, the Company issued and sold 40 of the Company’s units (“Units”) to the Adviser (the “Initial Unitholder”), which were acquired for an initial capital contribution of $1 on January 18, 2023 in reliance upon the available exemptions from registration requirements of Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). As of June 30, 2025, the Company has closed on $66,780 in capital commitments. The Company’s initial drawdown occurred on March 31, 2023 with the sale and issuance of Units at an aggregate purchase price of $3,000 or $25.00 per Unit. Prior to the issuance of Units on March 31, 2023, the Initial Unitholder’s initial seed capital was withdrawn from the Company and its Units were canceled. As of June 30, 2025, $16,700 of capital commitments were drawn and $50,080 were unfunded.

To seek to achieve its investment objective, the Company expects to invest in directly originated cash flow loans issued to sponsor-owned upper-middle-market companies and in niche specialty finance loans with attractive risk-return characteristics. Borrowers in the Company’s cash flow strategy are expected to typically generate $25,000 to $250,000 or more of EBITDA (defined below), operate in non-cyclical industries, demonstrate defensive business models, and be owned by leading private equity firms. The Company’s specialty finance investments will encompass asset-based lending to asset-rich companies in a variety of industries. The Company’s investments in portfolio companies are referred to herein as “Portfolio Investments”.

The Company was permitted to hold closings at any time during the offering period (the “Offering Period”), which ended on
February 9, 2025.

The term of the Company is expected to be seven years from the end of the Offering Period (unless terminated earlier or the Company effectuates an Exchange Listing (defined below) as set forth in the Limited Liability Company Agreement of the Company (as amended, restated or otherwise modified from time to time, the “LLC Agreement”)), but may be extended by the Company’s board of directors (the “Board”) for up to two consecutive one year periods upon approval of the Company’s independent directors and the approval of unitholders of the Company (“Unitholders”), which approval will be obtained through a non-1940 Act vote as described in Item 11 of the Company’s registration statement on Form 10. The Company may be dissolved and its affairs wound up prior to the end of the term under the circumstances set forth in the LLC Agreement.

At any time prior to the end of the term, subject to any requirements of the 1940 Act and applicable law, the Board may, without the approval of the Unitholders, cause the Company (or any successor entity to the Company) to be merged with and into an affiliated entity that is regulated under the 1940 Act, whose securities are listed for trading on a national securities exchange, and that will have a total net asset value of at least $1,000,000 immediately after the closing of such merger, subject to any limitations under the 1940 Act (an “Exchange Listing”). In connection with, and prior to, any such Exchange Listing, subject to any requirements of the 1940 Act and applicable law, the Board may, without the approval of Unitholders, cause the Company to complete (i) the sale, exchange or disposition of all or a portion of the assets of the Company, or (ii) a conversion of the Company into a corporation incorporated in a state determined by the Board, either through a conversion in accordance with applicable law, a merger with or into an existing corporation or otherwise in which all Units will be converted into or exchanged for shares of common stock of the resulting corporation. If the Company is unable to effectuate an Exchange Listing prior to the end of its term, the Company will use commercially reasonable efforts to wind down or liquidate pursuant to the procedures set forth in the LLC Agreement.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

June 30, 2025

(in thousands, except unit and per unit amounts)

Note 2. Summary of Significant Accounting Policies

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated.

Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X, as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reported period. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2025.

In the opinion of management, all adjustments which are of a normal recurring nature considered necessary for the fair presentation of consolidated financial statements have been included.

The significant accounting policies consistently followed by the Company are:

(a)

Investment transactions are accounted for on the trade date.

(b)

In accordance with GAAP and the 1940 Act, the Company’s assets will generally be valued as follows:

(i)

securities or other instruments (other than as referred to in clauses (ii) and (iii) below) for which market quotes are readily available and deemed to represent fair value under GAAP will be valued based on quotes obtained from a quotation reporting system, market makers or pricing services (when deemed to represent fair value under GAAP);

(ii)

exchange-traded options, futures and options on futures will be valued at the settlement price determined by the exchange or through the use of a model such as Black-Scholes;

(iii)

short-term investments with maturities of sixty (60) days or less generally will be valued at amortized cost; and

(iv)

securities, loans or other instruments for which market quotes are not readily available or reliable under GAAP will be valued as described below:

the quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of SLR responsible for the Portfolio Investment;

preliminary valuation conclusions are then documented and discussed with senior management of the Adviser;

the audit committee of the Board reviews the preliminary valuations of the Adviser and third-party valuation specialist, if any, that may from time to time be engaged by the Board, and responds to the valuation recommendations to reflect any comments; and

the Board discusses valuations and determines the fair value of each investment in the Company’s portfolio in good faith based on the input of the Adviser, the audit committee, and third-party valuation specialist, if any.

The valuation principles set forth above may be modified from time to time without notice to Unitholders, in whole or in part, as determined by the Board in its sole discretion.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

June 30, 2025

(in thousands, except unit and per unit amounts)

The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule 2a-5 under the 1940 Act; and (6) maintain recordkeeping requirements under Rule 2a-5.

When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Company will consider the pricing indicated by the external event to corroborate the valuation. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material.

Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the six months ended June 30, 2025, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.

ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.

Level 2: Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.

Level 3: Unobservable inputs for the asset or liability.

In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.

(c)

Gains or losses on investments are calculated by using the specific identification method.

(d)

The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized, and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring fee income, as well as management fees and other fee income for services rendered, if any, are recorded as other income when earned.

(e)

The Company intends to comply with the applicable provisions of the Code pertaining to RICs to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

June 30, 2025

(in thousands, except unit and per unit amounts)

(f)

Book and tax basis differences relating to Unitholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.

(g)

Distributions to Unitholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.

(h)

In accordance with Regulation S-X and ASC Topic 810—Consolidation, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.

(i)

The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against the U.S. dollar on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.

(j)

In accordance with ASC 835-30, the Company reports origination and other expenses related to certain debt issuances, if any, as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.

(k)

The Company records expenses related to applicable equity offering costs as a charge to capital upon the sale of units, in accordance with ASC 946-20-25.

(l)

Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when principal or interest cash payments are past due 30 days or more and/or when it is no longer probable that principal or interest cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.

(m)

The Company records expenses directly related to its organization as incurred.

(n)

The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

Note 3. Agreements and Related Party Transactions

Pursuant to the Investment Management Agreement we have entered into with the Adviser, we intend to pay the Adviser certain management and incentive fees prior to and following an Exchange Listing. Prior to an Exchange Listing, the Adviser has been appointed to provide administrative and coordination services to the Company (in such capacity, the “Administrative Coordinator”). The Company will pay an administration fee to the Administrative Coordinator for such administrative and coordination services. Following an Exchange Listing, we intend to enter into a separate administration agreement with an affiliate pursuant to which

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

June 30, 2025

(in thousands, except unit and per unit amounts)

administrative services would be provided to the Company, as described further below. The cost of the base management fee, the incentive fee and the administration fee will ultimately be borne by our Unitholders.

Management Fees

The Company will pay the Adviser a management fee prior to an Exchange Listing (as the same may be adjusted pursuant to the LLC Agreement and the Investment Management Agreement, the “Pre-Exchange Listing Management Fee”) and a management fee following an Exchange Listing (as the same may be adjusted pursuant to the LLC Agreement and the Investment Management Agreement, the “Post-Exchange Listing Management Fee” and, together with the Pre-Exchange Listing Management Fee, the “Management Fee”). The Management Fee will be payable quarterly in arrears, as follows:

•

Pre-Exchange Listing. Prior to an Exchange Listing, the Pre-Exchange Listing Management Fee will be calculated as of the close of business on the last day of each calendar quarter in an amount equal to 1.50% per annum of Invested Capital (defined as, as of any date, the sum of (i) capital contributions to the Company used to make Portfolio Investments and (ii) the total amount of credit drawn on subscription or similarly structured credit facilities).

•

Post-Exchange Listing. Following an Exchange Listing, the Post-Exchange Listing Management Fee will be an amount equal to 1.50% per annum of the average value of the Company’s total assets at the end of the two most recently completed calendar quarters; provided, however, the Post-Exchange Listing Management Fee will be calculated at an annual rate of 1.00% of the average value of the Company’s total assets at the end of the two most recently completed calendar quarters that exceeds the product of (i) 200% and (ii) the value of the Company’s total net assets at the end of the immediately preceding calendar quarter.

The Management Fee will be appropriately adjusted for any stub period. The Adviser may arrange for the Company to direct to a placement agent any portion of the Management Fee which the Adviser is owed for purposes of paying any placement fee that the Adviser owes to such placement agent.

The Adviser will have the right, in its sole discretion, to waive or reduce, as well as recoup in a subsequent period, the Management Fee to which the Adviser is entitled in respect of all Unitholders’ Units in any particular calendar quarter. Any such Management Fee may be recouped by the Adviser in a future calendar quarter within three years of the date of the applicable waiver of the Management Fee and any such recoupment would be conditioned on the Company’s expense ratio at the time of recoupment, but after giving effect to the recoupment, being equal to or less than the expense ratio at the time of the waiver. The Adviser does not have a current intention to waive any Management Fees.

Incentive Fee

Distributions. Prior to an Exchange Listing, the Company makes distributions out of two categories: Current Proceeds and Disposition Proceeds (collectively referred to as “Investment Proceeds”). “Disposition Proceeds” means all amounts received by the Company upon the disposition of an investment, including full or partial repayments or amortization of principal (but excluding Current Proceeds). “Current Proceeds” means all proceeds from investments, including interest income, fee income, prepayment fees and exit fees, other than Disposition Proceeds, less Company expenses. The Adviser apportions each Unitholder’s pro rata share of Investment Proceeds between Disposition Proceeds and Current Proceeds.

Pre-Exchange Listing Incentive Fee. Prior to an Exchange Listing, and subject to availability, the Company will cause distributable cash to be distributed to Unitholders and to be paid to the Adviser as an incentive fee (the “Pre-Exchange Listing Incentive Fee”). Amounts of Investment Proceeds apportioned to Unitholders are divided between and distributed to Unitholders, on the one hand, and the Adviser, on the other hand, in the following amounts and order of priority:

(i) Disposition Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as a Pre-Exchange Listing Incentive Fee, on the other hand, in the following amounts and order of priority:

(A) First, Return of Capital Contributions: 100% to such Unitholder until such Unitholder has received cumulative distributions of Investment Proceeds pursuant to this clause (A) equal to such Unitholder’s total capital contributions to the Company (including amounts contributed to pay Pre-Exchange Listing Management Fees, Pre-Exchange Listing Administration Fees (defined below), Organizational Expenses (defined below) and other Company expenses);

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

June 30, 2025

(in thousands, except unit and per unit amounts)

(B) Second, Unitholder Preferred Return: 100% of all remaining Disposition Proceeds to Unitholders until they have each received cumulative distributions of Investment Proceeds, without duplication, pursuant to this clause (B) and clause (D) below and clauses (ii)(A) and (ii)(C) below equal to 6% per annum, compounded annually, on Unitholders’ capital contributions to the Company (including amounts contributed to pay Pre-Exchange Listing Management Fees, Pre-Exchange Listing Administration Fees, Organizational Expenses and other Company expenses), determined on the basis of all capital contributions made by such Unitholder and considering all distributions (including the subject distribution) under this “—Pre-Exchange Listing Incentive Fee” made to such Unitholder (computed from the dates that such capital contributions were due (or, if actually made later, the date on which such capital contributions were actually made) until the date that the Company, in its sole discretion, designates distributable cash as available for distribution or, if no such designation is made, the occurrence of an Event of Dissolution, as defined in the LLC Agreement) (the “Preferred Return”);

(C) Third, Adviser Catch Up: 100% of all remaining Disposition Proceeds to the Adviser as a Pre-Exchange Listing Incentive Fee, until the Adviser has received payments of Investment Proceeds with respect to Unitholders pursuant to this clause (C) and clause (ii)(B) below equal to 10% of the total amounts due to Unitholders and earned by the Adviser pursuant to clause (B) above and this clause (C) and clauses (ii)(A) and (ii)(B) below; and

(D) Fourth, 90%/10%: 90% of all remaining Disposition Proceeds to Unitholders and 10% of all remaining Disposition Proceeds to the Adviser as a Pre-Exchange Listing Incentive Fee.

In no event will the Adviser receive amounts of Pre-Exchange Listing Incentive Fees under clauses (i)(C) and (i)(D) above in excess of the percentage of the Disposition Proceeds actually distributed to Unitholders pursuant to clauses (i)(B), (i)(C) and (i)(D) above.

In no event will the Adviser receive amounts attributable to Disposition Proceeds that, as of any distribution or payment date, exceed 20% of cumulative realized capital gains net of all cumulative realized capital losses and unrealized capital depreciation.

(ii) Current Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as a Pre-Exchange Listing Incentive Fee, on the other hand, in the following amounts and order of priority:

(A) First, Unitholder Preferred Return: 100% of all Current Proceeds to Unitholders until Unitholders have received cumulative distributions of Investment Proceeds, without duplication, pursuant to this clause (A) and clause (C) below and pursuant to clause (i)(B) and clause (i)(D) above equal to the Preferred Return;

(B) Second, Adviser Catch Up: 100% of all remaining Current Proceeds to the Adviser as a Pre-Exchange Listing Incentive Fee until the Adviser has received payments of Investment Proceeds with respect to Unitholders pursuant to this clause (B) and clause (i)(C) above equal to 10% of the total amounts due to Unitholders and earned by the Adviser pursuant to clause (A) above and this clause (B) and pursuant to clause (i)(B) and clause (i)(C) above; and

(C) Third, 90%/10%: 90% of all remaining Current Proceeds to Unitholders and 10% of all remaining Current Proceeds to the Adviser as a Pre-Exchange Listing Incentive Fee.

In no event will the Adviser receive amounts of Pre-Exchange Listing Incentive Fees under clauses (ii)(B) and (ii)(C) above in excess of the percentage of the Current Proceeds actually distributed to Unitholders pursuant to clauses (ii)(A), (ii)(B) and (ii)(C) above.

Post-Exchange Listing Incentive Fee. Following an Exchange Listing, the Company will pay an incentive fee to the Adviser consisting of two parts, as follows (the “Post-Exchange Listing Incentive Fee” and, together with the Pre-Exchange Listing Incentive Fee, the “Incentive Fee”):

(i)

Pre-Incentive Fee Net Investment Income. One part will be calculated and payable quarterly in arrears based on the net investment income for the immediately preceding calendar quarter.

For this purpose, Pre-Incentive Fee Net Investment Income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued by the Company during the calendar quarter, minus the Company’s operating expenses for the quarter (including the Post-Exchange Listing Management Fees, expenses payable under an administration

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

June 30, 2025

(in thousands, except unit and per unit amounts)

agreement, and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the Post-Exchange Listing Incentive Fee).

Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Pre-Incentive Fee Net Investment Income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, will be compared to a “hurdle rate” of 1.75% per quarter (7.00% annualized). The Company’s Pre-Incentive Fee Net Investment Income used to calculate this part of the Post-Exchange Listing Incentive Fee is also included in the amount of its gross assets used to calculate the 1.50% Post-Exchange Listing Management Fee.

The Company will pay the Adviser a Post-Exchange Listing Incentive Fee with respect to the Company’s Pre-Incentive Fee Net Investment Income in each calendar quarter as follows:

no Post-Exchange Listing Incentive Fee in any calendar quarter in which the Company’s Pre-Incentive Fee Net Investment Income does not exceed the quarterly hurdle rate of 1.75%;

ii.

100% of the Company’s Pre-Incentive Fee Net Investment Income with respect to that portion of such Pre-Incentive Fee Net Investment Income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter (8.75% annualized); this portion of the Pre-Incentive Fee Net Investment Income (which exceeds the hurdle but is less than 2.1875%) is referred to herein as the “catch-up.” The “catch-up” is meant to provide the Adviser with 20% of the Company’s Pre-Incentive Fee Net Investment Income as if a hurdle did not apply if this Pre-Incentive Fee Net Investment Income exceeds 2.1875% in any calendar quarter; and

iii.

20% of the amount of the Company’s Pre-Incentive Fee Net Investment Income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) payable to the Adviser (once the hurdle is reached and the catch-up is achieved, 20% of all Pre-Incentive Fee Net Investment Income thereafter is allocated to the Adviser).

These calculations will be appropriately pro-rated for any period of less than three months.

(ii) Capital Gains Fee. The second part of the Post-Exchange Listing Incentive Fee, the “Capital Gains Fee”, will be determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Management Agreement as set forth below), commencing as of the end of the first fiscal year following an Exchange Listing, and will equal 20.0% of the Company’s realized capital gains, if any, on a cumulative basis through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation as of each fiscal year end, less the amount of any previously paid capital gain Post-Exchange Listing Incentive Fees, with respect to the Company; provided that the Post-Exchange Listing Incentive Fee determined as of the end of the fiscal year in which an Exchange Listing is completed will be calculated for a period of shorter than twelve calendar months to take into account any realized capital gains computed net of all realized capital losses and unrealized capital depreciation. In the event that the Investment Management Agreement will terminate as of a date that is not a calendar year end, the termination date will be treated as though it were a calendar year end for purposes of calculating and paying a Capital Gains Fee.

Administration Fees and Expenses

Pre-Exchange Listing Administration Fees. The Company will pay SLR, in its capacity as the Administrative Coordinator, a fee (the “Pre-Exchange Listing Administration Fee” or “Administration Fee” ), calculated as of the close of business in New York, New York on the last day of each calendar quarter (the “Administration Fee Calculation Date”), in an amount equal to 0.08% per annum of the average Cost Basis (defined as, as of any date, the aggregate accreted and amortized cost of all Portfolio Investments, including (i) any amounts reinvested in Portfolio Investments and (ii) the cost of Portfolio Investments acquired using leverage), as measured on the last day of the preceding quarter and the last day of the current quarter for the period ended and payable quarterly in arrears after such Administration Fee Calculation Date. The Pre-Exchange Listing Administration Fee will not offset any fees paid to the Adviser. The Administrative Coordinator will be responsible for all expenses of its own staff responsible for (i) certain on-going, routine,

Table of Contents

SLR PRIVATE CREDIT BDC II LLC

Notes to Consolidated Financial Statements (unaudited) (continued)

June 30, 2025

(in thousands, except unit and per unit amounts)

non-investment-related administrative services for the Company, (ii) the coordination of various third-party services needed or required by the Company and (iii) certain Unitholder servicing functions.

The Pre-Exchange Listing Administration Fee will be appropriately adjusted for any stub period.

The Administrative Coordinator will have the right, in its sole discretion, to waive, as well as recoup in a subsequent period, the Pre-Exchange Listing Administration Fee to which it is entitled in respect of all Unitholders’ Units in any particular calendar quarter. Any such Pre-Exchange Listing Administration Fee may be recouped by the Administrative Coordinator in a future calendar quarter within three years of the date of the applicable waiver of the Pre-Exchange Listing Administration Fee and any such recoupment would be conditioned on the Company’s expense ratio at the time of recoupment, but after giving effect to the recoupment, being equal to or less than the expense ratio at the time of the waiver. The Adviser does not have a current intention to waive any Pre-Exchange Listing Administrative Fee.

Post-Exchange Listing Administration Expenses. In connection with an Exchange Listing, and subject to Board approval, the Company intends to enter into an administration agreement with SLR Capital Management, LLC (“SCM”) pursuant to which SCM will provide administrative services to the Company. For providing these services, facilities and personnel, the Company will reimburse SCM for the Company’s allocable portion of overhead and other expenses incurred by SCM in performing its obligations under the administration agreement (together with the Pre-Exchange Listing Administration Fee, the “Administration Expenses”).

For the three and six months ended June 30, 2025, the Company incurred $106 and $192, respectively, in Management Fees, $8 and $15, respectively, in Administration Fees and $0 and $0, respectively, in Incentive Fees. For the three and six months ended June 30, 2024, the Company incurred $106 and $201, respectively, in Management Fees, $6 and $11, respectively, in Administration Fees and $0 and $0, respectively, in Incentive Fees.

Payment of Expenses under the Investment Management Agreement

The Company (directly or indirectly) bears:

(i)

all of its fees, costs, expenses and liabilities, all of its investment-related fees, costs, expenses and liabilities (including with respect to amounts incurred prior to the Company’s initial closing) and all of its other operating fees, costs, expenses and liabilities, including all fees, due diligence costs and other fees, costs, expenses and liabilities related to the identification, sourcing, evaluation, pursuit, acquisition, holding, appraisals, asset management, restructuring and disposing of investments, including all reasonable travel-related fees, costs, expenses and liabilities (such as lodging and meals), all fees, costs, expenses and liabilities of legal counsel and financial and other advisers incurred in connection therewith, all fees, costs, expenses and liabilities of information technology services relating to the ongoing management of investments, and all other investment-related fees, costs, expenses and liabilities (to the extent not reimbursed by the relevant portfolio company);

(ii)

all fees, costs, expenses and liabilities related to any audits or agreed upon procedures, tax forms and return preparations and filings, custodian fees and expenses, fund accounting, administrator services, financial statement preparation and reporting, web services for the benefit of Unitholders, delivery costs and expenses in connection with reporting obligations and communications and compliance services;

(iii)

all fees, costs, expenses and liabilities relating to insurance policies (including director and officer liability insurance) maintained by or for the Company, including in respect of Portfolio Investments and/or personnel of the Adviser, the Adviser in its capacity as Administrative Coordinator and their affiliates;

(iv)

other administrative fees, costs and liabilities;

SLR Private Credit BDC II LLC 10-Q